Management of Breast Cancer in Older Women

個数:
電子版価格
¥26,639
  • 電子版あり

Management of Breast Cancer in Older Women

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 413 p.
  • 言語 ENG
  • 商品コード 9781848002647
  • DDC分類 616

Full Description

I was looking at Mrs T - all 45 kilos of her - with somewhat puzzled thoughts. I had prescribed her capecitabine at very prudent doses, in view of her 91-year-old kidneys and physiology. She had reduced my treatment even further, "because it was making her tired." As a result, she was taking a grand total of 500 mg of capecitabine a day. Yet, her metastatic, ER/PR-negative, Her2-positive breast cancer was undoubtedly responding. Her pain was improving and her chest mass was shrinking, as were her lung metastases... What was the secret of that response? Were Mrs T's kidneys eli- nating even less drug than predicted by her creatinine clearance? Was her sarcopenia altering drug distribution? Was she absorbing more drug than average? Or was her tumor exquisitely sensitive to fluoropyrimidines? "Physicians," said Voltaire, "pour drugs they know little for diseases they know even less into patients they know no- ing about." Medicine has made tremendous progress since the eighteenth century. Yet, there are fields where quite a lot remains to be learned. In developed countries, 25% of breast cancers occur in patients aged 75 years and older. Yet, these patients represent only 4% of the population of traditional clinical trials. That ought to let us wonder how relevant data acquired in patients in their 60s are to a nonagenarian. Fortunately, geriatric oncologists have been stepping up to the task and have gen- ated data to help us to treat such patients.

Contents

Background and Epidemiology.- Basic Science of Breast Cancer in Older Patients.- Tumor Biology and Pathology.- Clinical Epidemiology and the Impact of Co-Morbidity on Survival.- Special Considerations in the Management of Older Women.- Comprehensive Geriatric Assessment.- A Practical Mini-Guide to Comprehensive Geriatric Assessment.- Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Breast Cancer Treatment.- Impact of Hormone Replacement Therapy on Breast Cancer.- Experiences of a Multidisciplinary Elderly Breast Cancer Clinic: Using the Right Specialists, in the Same Place, with Time.- Therapeutics.- Mammographic Breast Screening in Elderly Women.- Primary Endocrine Therapy for the Treatment of Early Breast Cancer in Older Women.- Peroperative Radiotherapy.- General and Local Anesthetics.- The Surgical Management of Breast Cancer in Elderly Women.- Breast Reconstruction.- Adjuvant Endocrine Therapy.- Adjuvant Chemotherapy.- Adjuvant Radiotherapy.- Prevention and Treatment of Skeletal Complications.- Medical Management of Advanced Disease.- The Use of Chemotherapy in Elderly Cancer Patients: Dose Adjusting, Drug Interactions, and Polypharmacy.- Psychosocial Considerations.- Delayed Presentation of Breast Cancer in Older Women.- Patient Decision Making.- Culture, Ethnicity, and Race: Persistent Disparities in Older Women with Breast Cancer.- Supportive, Palliative and End-of-Life Care for Older Breast Cancer Patients.

最近チェックした商品